We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Healio Pulmonology has compiled the top news on COPD ...
Clinical Trials Arena on MSN
Merck begins Phase III ENHANCE-3 trial of Ohtuvayre in COPD
The placebo-controlled, randomised, double-blind study plans to enrol around 2,136 patients across 28 countries.
GOLD 2026 narrows LAMA monotherapy's niche in COPD, even as tiotropium Respimat, the class's only asthma-indicated agent, rests on the largest dedicated respiratory device safety trial ever run.
Prioritizing communications between patients and health care providers and increasing patient education about chronic obstructive pulmonary disease (COPD) could help improve patient care, according to ...
Clinical Trials Arena on MSN
Aer Therapeutics’ mucus-targeting drug fails Phase IIa COPD trial
The drug could also be used in indications including asthma and CF, but Aer Therapeutics has not confirmed whether it will ...
One patient could only walk 15 to 20 steps before needing to get back on her oxygen, making it difficult to find motivation to engage in daily activities. Another patient struggled with severe ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
If you or a loved one suffers from severe COPD (Chronic Obstructive Pulmonary Disease) or advanced emphysema, you know just how difficult it can be to breathe. Every step can be a struggle. Now, there ...
As November marks COPD Awareness Month, Florida physicians are sounding the alarm about chronic obstructive pulmonary disease ...
Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results